Source link : https://newshealth.biz/health-news/can-glp-1s-protect-against-obesity-related-cancers/
New data suggest that glucagon-like peptide 1 (GLP-1) receptor agonists, used to treat diabetes and obesity, may also help guard against obesity-related cancers. In a large observational study, new GLP-1 agonist users with obesity and diabetes had a significantly lower risk for 14 obesity-related cancers than similar individuals who received dipeptidyl peptidase-4 (DPP-4) inhibitors, which are […]
The post Can GLP-1s Protect Against Obesity-Related Cancers? first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-28 09:37:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8